| Revenue growth | Flat sales performance indexed against comparable 12-month period. |
|---|---|
| Margins | PAT growth suggests margin expansion despite flat revenue. |
Growth
PAT increased by 19% YoY; Sales remained flat for the fiscal year 2025-26.
Outlook
Targeting INR 86 crores in productivity savings; focus on data platforms and AI for operational efficiency.
Risks
Identified headwinds include inflation, media transformation, and a changing retail landscape.
Last quarter's promises, checked
Delivered
- Guided consistent mid-single digit sales growth → delivered flat (= MISS)
- Guided 8% compounded profit growth → delivered 19% PAT growth (= BEAT)
- Guided Rs. 93 Cr productivity savings → delivered Rs. 86 Cr target for next year (= PARTIAL)
Partly delivered
- Guided productivity as fuel for growth → delivered margin expansion but failed to convert to revenue growth (= PARTIAL)
Missed
- Guided mid-single digit sales growth → delivered flat sales (= MISS)
Earnings Call filed with BSE, NSE: PGHH. Summary written with AI assistance from the document.
Procter & Gamble Hygiene & Healthcare Ltd: key numbers
- Share price
- ₹6,909.00
- Market cap
- ₹22,427 Cr
- Revenue (annual)
- ₹4,290 Cr
- Net profit (annual)
- ₹856.5 Cr
- P/E (TTM)
- 28.4×Sector 42.5×
- Promoter holding
- 70.64%+0.00% QoQ
- FII holding
- 0.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Procter & Gamble Hygiene & Healthcare Ltd
All →Procter & Gamble Hygiene & Healthcare Board Meeting Date
P&G Hygiene and Health Care will hold a board meeting on November 12, 2026, to consider unaudited standalone financial results for the half-year ending September 2026.
Procter & Gamble Hygiene & Healthcare Management Change
Procter & Gamble Hygiene and Health Care Limited has appointed Ms. Flavia Machado as Company Secretary and Compliance Officer, effective September 29, 2026.
Procter & Gamble Hygiene & Healthcare Price Movement Clarification
P&G Hygiene and Health Care denied baseless rumors of potential delisting or winding up. Filed under Reg 30(11) due to material price movement.
Procter & Gamble Hygiene & Healthcare Management Change
P&G Hygiene and Health Care announced appointment of Ms. Srividya Srinivasan as Whole-time Director effective July 1, 2026. Shareholders approved the five-year term at the 62nd AGM on September 8, 2026.
Procter & Gamble Hygiene & Healthcare Annual General Meeting
Procter & Gamble Hygiene and Health Care Ltd held its 62nd Annual General Meeting on September 8, 2026, to discuss financial statements, dividends, and director appointments.
Procter & Gamble Hygiene & Healthcare Business Update
Procter & Gamble Hygiene and Health Care Ltd has released its Business Responsibility and Sustainability Report for the financial year ended March 31, 2026. This filing details the company's performance on ESG metrics.